Antibody–Drug Conjugates (ADC)
Adcetris (brentuximab vedotin) in Kuwait — Regulatory and Supply Information
CD30-directed antibody–drug conjugate (MMAE payload) for classical Hodgkin lymphoma (frontline stage III/IV with AVD — ECHELON-1, and post-transplant consolidation), systemic anaplastic large-cell lymphoma (ALCL) with CHP (ECHELON-2), CD30-expressing peripheral T-cell lymphoma, and CD30-positive cutaneous T-cell lymphoma. Dosed 1.8 mg/kg (max 180 mg) IV every 3 weeks.
Prescription-only medicine. No pricing is published on this page. Prescription-medicine pricing is not advertised to the public in this market.
This page is informational and is not an advertisement, a promotional communication, or medical advice. It does not offer any medicine for sale to the public. Treatment decisions belong to your treating physician.
What this medicine is
- Active ingredient
- brentuximab vedotin
- Marketing authorisation holder
- Takeda / Seagen
- Therapeutic class
- Antibody–Drug Conjugates (ADC)
Presentations and dosage forms
- 50 mg lyophilized vial (IV infusion)
Storage, cold chain and handling
Refrigerate 2–8°C, protect from light, do not freeze.
The regulatory position in Kuwait
Medicines in Kuwait are regulated by the Ministry of Health. This page is informational and is not an advertisement.
Ministerial Decision No. 9/2025, effective 15 January 2025, requires prior authorisation from the Drug Inspection Department for all advertising of pharmacies, medicines and health products, and states explicitly that this includes websites and social media. It provides that the pricing of health products may not be displayed without approval, that promoting discounts or offers requires authorisation, and that superlatives are not permitted. Penalties reach KD 3,000 and up to three years' imprisonment.
For that reason this page carries no pricing, no offer and no promotional description of any medicine. It sets out what the medicine is, how it is presented and handled, and which authority to approach.
We have not verified Kuwait's personal-import procedure from a primary source. Confirm the applicable requirements directly with the Ministry of Health before acting on anything described here.
We have not verified Kuwait's personal-import procedure. We do not describe one here. Confirm the current requirements with the Ministry of Health.
Documentation typically required
- A valid prescription from the treating physician
- A medical report describing the diagnosis and the treatment plan
- Proof of identity for the patient
- For a hospital or clinic: the establishment licence and the request of the responsible pharmacist
Official sources
Why the same medicine is priced differently in Türkiye
This is how the Turkish pricing system works. These are published facts about a state mechanism, not a claim about what we charge.
- Turkish medicine prices are calculated from a fixed pharmaceutical euro rate rather than the spot exchange rate. Under Decision No. 11031 (Resmî Gazete 33194, 12 March 2026) that rate is set at 65% of the previous year's average Turkish Central Bank euro selling rate.
- The reference price is derived from the lowest ex-factory price in a basket of five to ten EU member states designated by the Ministry of Health.
- A mandatory public discount of roughly 28–41% is then applied, depending on the product category and price band. The band thresholds change with each SUT revision, so we do not reproduce them here.
Official published lists — our figures appear nowhere
We publish no price. Each authority below publishes its own list. Read them directly:
- TİTCK — Türkiye Medicines and Medical Devices Agency, published price list
- Ministry of Health, State of Kuwait
Compare them yourself.
For international context: RAND Corporation, analysing 2022 data and publishing in February 2024, found US prices were 278% of prices in 33 other high-income countries, rising to 422% for brand-name originator medicines.
How to obtain a price
We do not publish prices. The price depends on the dose, the number of vials and the number of treatment cycles. Send your prescription and medical report and you will receive a written quote within 24 hours.
Sourced through Türkiye pharmacy channels · İTS serial-traceable — every Turkish pack carries an İTS karekod encoding the GTIN, serial number, batch and expiry, which can be checked against Türkiye's Pharmaceutical Track and Trace System.
How to obtain a priceSearch terms for this medicine
The same molecule is searched under several names. All of the following refer to the same product:
- Adcetris
- brentuximab vedotin
- أدسيتريس
- برنتوكسيماب فيدوتين
- Adcetris Kuwait
- أدسيتريس الكويت
- brentuximab vedotin MOH Kuwait
- Adcetris prescription
- أدسيتريس وصفة طبية
Frequently asked questions
Prescription-based enquiry
If you hold a valid prescription from a treating physician in Kuwait, you can send us the prescription details and we will reply with the regulatory and documentation position for that specific product. We do not publish pricing for Kuwait and we do not sell to the public.
Send a prescription-based enquiryBackground reading
- Why medicines cost less in Türkiye
- How to verify a medicine is genuine
- WHO falsified medicine alerts
- Named patient supply
- For healthcare professionals
- Import guide — Kuwait
- Hospital & procurement — Kuwait
- Kuwait medicines
- Adcetris — Saudi Arabia
- Adcetris — Bahrain
- Adcetris — Oman
- Adcetris — United Arab Emirates
- Adcetris — Qatar
- Adcetris — Azerbaijan
Related medicines
Medically reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-07-29 · Ministry of Health — Drug Inspection Department
For healthcare professionals
Prescribers, hospital and specialty pharmacies, oncology centres and procurement departments: named patient supply, documentation and the sourcing workflow.